Pag-aaral pangklinika para sa Migraine sa Illinois
6 pag-aaral para sa Migraine ang naghahanap ng mga kalahok sa mga site sa Illinois.
Mga Lungsod sa Illinois
Opisyal na teksto ng pag-aaral (English)
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Chicago Headache Center & Research Institute, Chicago
- AMR-Baber Research Inc, Naperville
Nagre-recruitPhase 3
Edad 6 hanggang 17 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Chicago Headache Center & Research Institute, Chicago
- AMR-Baber Research Inc, Naperville
Nagre-recruitPhase 3
Edad 6 hanggang 17 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT04649242Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Chicago Headache Center & Research Institute /ID# 248625, Chicago
- Ascension Saint Alexius /ID# 275261, Hoffman Estates
Nagre-recruitPhase 3
Edad 6 hanggang 17 · Lahat ng kasarian · Na-update Set 14, 2026 · NCT05125302A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Cedar Crosse Research Center, Chicago
- Chicago Headache Center & Research Institute, Chicago
- Healthcare Research Network II, LLC, Flossmoor
- at 1 pa
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT07645924Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks
- Chicago Headache Center & Research Inst /ID# 272345, Naperville
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 10, 2026 · NCT07310290Effectiveness of Magnesium in Addition to Prochlorperazine for the Treatment of Migraines
- Advocate Christ Medical Center Emergency Department, Oak Lawn
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 22, 2026 · NCT06904287Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.